|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
18 March 2013 |
|
Main ID: |
NCT00000188 |
|
Date of registration:
|
20/09/1999 |
|
Primary sponsor: |
|
|
Public title:
|
Selegiline in Treatment of Cocaine Dependence - 2
|
|
Scientific title:
|
Selegiline in Treatment of Cocaine Dependence |
|
Date of first enrolment:
|
September 1994 |
|
Target sample size:
|
50 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00000188 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
|
|
|
Countries of recruitment
|
|
United States
| | | | | | | |
|
Contacts
|
|
Name:
|
James Cornish, M.D. |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
University of Pennsylvania |
| | |
|
Key inclusion & exclusion criteria
|
Please contact site for information.
Age minimum:
N/A
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Cocaine-Related Disorders
|
|
Intervention(s)
|
|
Drug: Selegiline
|
|
Primary Outcome(s)
|
|
Cocaine craving
|
|
Cocaine use
|
|
Retention
|
|
Secondary ID(s)
|
|
3R01DA012268
|
|
K20-00144-2
|
|
NIDA-00144-2
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|